Delegate Profile

Prof. Ronan Murphy

Job TitleDeputy Head

Company NameDublin City University


University of Newcastle-Upon-Tyne, UK (2010) Advanced Flow Cytometry. Max Plank Institute for Cell & Molecular Biology, Dresden, Germany (2004) Advanced Imaging. Dublin Institute of Technology (1997-1998) Dip IT. N.U.I. Galway: Cell and Molecular Biology Group, PhD Molecular Genetics of Hereditary Colorectal Cancer. N.U.I. Gal-way BSc (Hons) Biochemistry. London College of Music (1985-1989) A.L.C.M. 

Research interests
Currently Lecturer in Cell and Molecular Physiology, and Deputy Head for the School of Health & Human Performance, DCU. Dr. Murphy started his research career as a Clinical Research Scientist and Core Facilities Director (Molecular Genetics) in the Centre for Cardiovascular Science, Royal College of Surgeons in Ireland (1996-2000). He specialised in pharmacogenomics and stratification of clinical trials, and helped establish the first national DNA Bio-Bank. In 1998, Dr. Murphy was awarded a pres-tigious Post-Doctoral Fellowship from the Health Research Board of Ireland.

In 2000 he moved to TSRI, La Jolla where he studied Megakaryocytopoiesis, Thrombopoiesis and Platelet function. He returned to DCU in 2004, focusing on Integrative Cell and Molecular Physiology and Epigenetics. The research also involves applied and transla-tional research, focusing on the development of novel cellular and molecular diag-nostics and prognostics, and organotypic model development for therapeutic evalua-tion at the clinical and preclinical stages for numerous human trials. His group also studies epigenetics with respect to chronic disease management.

He is currently Vice Chair for Europe’s largest COST Action- EpiChemBio (CM1406- for Epigenetic Technologies and Applications, and is an Edi-torial Board Member for ‘Clinical Epigenetics’, ‘Journal of Cardiovascular Pharma-cology’ and ‘Frontiers in Physiology’. Current projects in this field include working with the European space agency (ESA) on the effect of space flight on cardiovascular epigenetics.

In September 2018, he was awarded and elected as a Sentinel of Sci-ence for his contribution to scientific reviewing and editorial duties (top 1% Global-ly) and was ranked 24th Internationally in the field of Molecular Biology and Genet-ics. He also helped develop the next generation ‘Burn Dressing’ for the US military and is currently developing a novel therapy for chronic ulcers.

Starting in October 2018, Dr. Murphy’s group is collaborating with one of Ireland’s top 3 innovative companies -, to develop novel Disruptive Technol-ogies to manage cognitive decline, dementia and inflammageing of the Neurovascu-lar Compartment.

Selected Publications

  • Non‑invasive assessment of skin barrier properties: investigating emerging tools for in vitro and in vivo applications Emer Duffy, Keana De Guzman, Robert Wallace, Ronan Murphy, and Aoife Morrin. In press Cosmetics.
  • Multi-System Deconditioning in 3-day Dry Immersion without Daily Raise. Steven De Abreu, Liubov Amirova, Ronan Murphy, Guillemette Gauquelin-Koch, Ve-ronique Raverot, Françoise Larcher, Marc-Antoine Custaud, Nastassia Navasiola-va. In press  Frontiers.
  • Moesin and Merlin Regulate Urokinase Receptor-Dependent Endothelial Cell Mi-gration, Adhesion and Angiogenesis. Degryse B, Britto M, Shan CX, Wallace RG, Rochfort KD, Cummins PM, Meade G, Murphy RP. Int J Biochem Cell Biol. 2017 May 1. pii: S1357-2725(17)30090-0. doi: 10.1016/j.biocel.2017.04.012. 


Conference Sessions

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.